AprilBio Co.,Ltd. (KOSDAQ:397030)

South Korea flag South Korea · Delayed Price · Currency is KRW
72,200
+2,700 (3.88%)
At close: Feb 27, 2026
278.80%
Market Cap 1.69T
Revenue (ttm) 8.97B
Net Income (ttm) -877.63M
Shares Out 23.34M
EPS (ttm) -39.00
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 864,476
Average Volume 590,345
Open 68,200
Previous Close 69,500
Day's Range 67,500 - 72,200
52-Week Range 11,980 - 74,000
Beta 1.57
RSI 61.74
Earnings Date n/a

About AprilBio

AprilBio Co., Ltd. develops long-acting type biobetter and antibody biologics. The company develops antibody drugs, double antibodies, long-acting antibody drugs, long-acting protein drugs, and ADC-applied antibodies. It is developing various products for use in the treatment of rare diseases, cancer, male infertility, autoimmune and inflammatory diseases. The company was founded in 2013 and is headquartered in Chuncheon-si, South Korea. [Read more]

Industry Biological Products, Except Diagnostic Substances
Founded 2013
Country South Korea
Stock Exchange KOSDAQ
Ticker Symbol 397030
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.